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Campbell replication conﬁ rms little or no eﬀ ect of 
community deworming 
For many years, international donors, philanthropists, 
and charities have poured money into deworming 
programmes for children in low-income and middle-
income countries in the belief they will contribute to 
improved health, school performance, and economic 
development.1 The Rockefeller Sanitary Commission 
started funding deworming programmes in 1909 for 
poor USA communities to eliminate the cause of the 
“laziness of the poorer classes”.2 The idea caught on, 
research emerged, and enthusiasm increased. By 2005, 
WHO attributed Japan’s economic boom to deworming 
programmes in the 1950s, and suggested their 
policy reduced world poverty and enabled women’s 
empowerment.3 In 2016, US-based deworming 
organisations were behind a national government 
programme in India treating 240 million children.4 
Tackling the evidence base behind these programmes, 
Vivian A Welch and colleagues5 have carried out a 
Campbell systematic review and network meta-analysis 
summarised in this issue of The Lancet Global Health. 
The authors examine trials of deworming for soil-
transmitted helminths as well as schistosomiasis, and 
synthesise data from 52 studies in nearly 1·3 million 
children. They conclude that mass deworming of 
children for soil-transmitted helminths has little to no 
eﬀ ect across a range of outcomes including growth, 
haemoglobin, cognitive development, and school 
attendance. The authors found a small eﬀ ect on weight 
gain for schistosomiasis, but little to no eﬀ ect for 
other outcomes. The eﬀ ect of deworming on societal 
economic productivity was uncertain owing to very low 
certainty evidence. 
Welch and colleagues’ review is a thorough and 
substantive replication of the Cochrane review,6,7 with 
additional sophisticated analyses and adjustments that 
take into account criticisms levelled by deworming 
advocates at the current Cochrane edition that we 
author. Since the ﬁ rst edition8 of the Cochrane review 
in 2000, advocates of deworming have ignored, 
ridiculed, or attacked the various editions.1,9 For the 
past 16 years we have added new studies as they have 
emerged, and evidence of no eﬀ ect has accumulated. 
We have unearthed large unpublished trials of no eﬀ ect 
now included in both reviews, and the controversy 
around our ﬁ ndings has helped to drive the demand 
for an independent replication10 of a single large 
study11 from Kenya cited extensively by advocates as 
the underpinning evidence base. The replication was 
published in 2015 and uncovered “various errors”, 
ultimately ﬁ nding little evidence for previously 
reported indirect eﬀ ects of deworming, although school 
attendance remained higher in the intervention group. 
Indeed, the disbelief around the Cochrane ﬁ ndings was a 
major reason for the Campbell replication.
The Campbell review includes appraisal of programmes 
for schistosomiasis, which is important because 
deworming advocates often conﬂ ate soil-transmitted 
helminths with schistosomiasis. This conﬂ ation oﬀ ers 
advocates a punchline for deworming for both soil-
transmitted helminths and schistosomiasis, although 
the parasites are diﬀ erent, with diﬀ erent distributions 
and requiring diﬀ erent drugs.12 The Campbell review 
also includes controlled before–after studies, uses 
network meta-analysis to compare the eﬀ ectiveness of 
deworming combined with nutritional supplementation, 
and assesses treatment externalities for individuals who 
do not receive treatment.13 The authors also include 
studies following up the stepped-wedge Kenyan study 
and a cluster randomised controlled trial in Uganda.14 
These follow-up studies ask whether a head start of 
1–2 years with exposure to deworming in one group 
of children (followed in both groups by up to 10 years 
of deworming) provided a demonstrable advantage in 
long-term health, development, and societal beneﬁ ts 
years later, and are widely cited by economists as solid 
evidence of long-term beneﬁ t. Welch and colleagues 
included these studies, assessing the risk of bias as high, 
and concluding that the eﬀ ects on long-term economic 
productivity are uncertain.5 We had not included 
these data in Cochrane, but our forthcoming detailed 
formal appraisal indicates the studies raise interesting 
hypotheses but do not provide reliable evidence of 
eﬀ ect—in line with Welch and colleagues’ assessment.15 
In summary, Welch and colleagues’ review is 
important. Not all systematic reviews on the same 
topic reach the same conclusion, but the convergence 
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between the Campbell and Cochrane reviews here 
could hardly be stronger.7 The additional network 
and subgroup analyses in the Campbell review ﬁ nd 
no evidence of spillover eﬀ ects, no synergistic eﬀ ects 
of co-interventions, and no evidence regarding any 
moderating impact of worm burden or the learning 
environment.5 Welch and colleagues encourage a 
further analysis using individual patient data analysis 
of deworming trials, although substantive new insights 
seem unlikely given the evidence of ineﬀ ectiveness 
for most outcomes across multiple analyses. In our 
view, the time has come for donors, governments, and 
philanthropists to call it a day on this magic bullet, and 
turn to broader problems related to childhood poverty.
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